Brief: Astrazeneca Pharma India Gets Import, Market Permission From DCGI For Osimertinib Film Coated Tablets
10/03/2021 10:51
March 10 (Reuters) - Astrazeneca Pharma India Ltd ASTR.NS :
* ASTRAZENECA PHARMA INDIA - GOT IMPORT, MARKET PERMISSION
FROM
DCGI FOR OSIMERTINIB FILM COATED TABLETS
Source text for Eikon: ID:nBSE5ySRSC
Further company coverage: ASTR.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Astrazeneca Pharma India
See all newsBrief: Astrazeneca Pharma Gets Permission To Import For Sale Of Trastuzumab Deruxtecan
India's Astrazeneca Pharma logs worst slide in two months on quarterly profit drop
Brief: Astrazeneca Pharma India March-Quarter PAT 448.8 Million Rupees
Brief: Astrazeneca Pharma India Recommends Dividend Of 36 Rupees Per Equity Share For Fy2025-26
Brief: Astrazeneca Pharma India Receives Permission To Import Durvalumab (Imfinzi) For Additional Indication